BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30107940)

  • 1. Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Sánchez Rodríguez E; Ríos León R; Mesonero Gismero F; Albillos A; Lopez-Sanroman A
    Gastroenterol Hepatol; 2018 Dec; 41(10):629-635. PubMed ID: 30107940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease.
    Simsek M; Meijer B; Mulder CJJ; van Bodegraven AA; de Boer NKH
    Ther Drug Monit; 2017 Dec; 39(6):584-588. PubMed ID: 29040228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR
    Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory determination of thiopurine levels in paediatric patients with inflammatory bowel disease].
    Martín-Masot R; Ortiz Pérez MP; Ramos Rueda N; Serrano Nieto J; Blasco-Alonso J; Navas-López VM
    An Pediatr (Engl Ed); 2020 Jul; 93(1):34-40. PubMed ID: 31784325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L; Sharif JA; Galloway P; McGrogan P; Bishop J; Russell RK
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
    Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
    Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of thiopurine metabolite monitoring in inflammatory bowel disease.
    Beswick L; Friedman AB; Sparrow MP
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC; Muktar H; Effken C; Mahajan PB
    Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
    Serpico MR; Maltz R; Crandall W; Bricker J; Dotson JL; Kim SC; Boyle B
    J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):341-345. PubMed ID: 29601433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study.
    Meijer B; Wilhelm AJ; Mulder CJJ; Bouma G; van Bodegraven AA; de Boer NKH
    Ther Drug Monit; 2017 Aug; 39(4):399-405. PubMed ID: 28489727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Stocco G; Martelossi S; Arrigo S; Barabino A; Aloi M; Martinelli M; Miele E; Knafelz D; Romano C; Naviglio S; Favretto D; Cuzzoni E; Franca R; Decorti G; Ventura A
    Inflamm Bowel Dis; 2017 Apr; 23(4):628-634. PubMed ID: 28296824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases?
    Frick S; Müller D; Kullak-Ublick GA; Jetter A
    Eur J Clin Pharmacol; 2019 Mar; 75(3):335-342. PubMed ID: 30610277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or Mercaptopurine.
    Munnig-Schmidt E; Zhang M; Mulder CJ; Barclay ML
    Inflamm Bowel Dis; 2018 Mar; 24(4):892-896. PubMed ID: 29522107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
    Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM; Ng JF; Dowling D
    Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease.
    Cangemi G; Barabino A; Barco S; Parodi A; Arrigo S; Melioli G
    Int J Immunopathol Pharmacol; 2012; 25(2):435-44. PubMed ID: 22697075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E; Norris E; Williams C; Dubinsky MC
    Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.